Literature DB >> 1711203

Enzyme activities in four different forms of human immunodeficiency virus 1 pol gene products.

Y W Hu1, C Y Kang.   

Abstract

Five cassettes of the pol gene of human immunodeficiency virus 1 were constructed and inserted under the control of the polyhedrin gene promoter of Autographa californica nuclear polyhedrosis virus by homologous recombination. The first cassette polF contains the full-length pol open reading frame; the second cassette pol100 starts with the first AUG codon of the pol gene and deletes 103 amino acids from the amino terminus of the pol gene product; the third cassette pol97 deletes the entire protease coding sequence; the fourth cassette pol66 deletes both the protease and endonuclease/integrase coding sequences; and the fifth cassette pol51 contains the reverse transcriptase coding sequences plus 39 3'-terminal nucleotides of the RNase H coding sequences. We have expressed these five forms of the pol gene in Spodoptera frugiperda SF9 cells and have analyzed for both reverse transcriptase and RNase H activities. The polF construct expressed several processed forms, 66 kDa, 51 kDa, and 34 kDa proteins, that were detected only by Western blot. In contrast, pol100, pol97, pol66, and pol51 products were expressed at high levels and were readily detectable in gels by staining. The levels of expression of these four products were estimated to be greater than 150 mg/liter of culture (5 x 10(8) cells). Activity gel analyses showed that the pol100, pol97, pol66, and pol51 products possess reverse transcriptase activity; however, only pol97 and pol66 have RNase H activity. Our results demonstrate that many forms, including partially cleaved forms of human immunodeficiency virus 1 pol gene products, possess reverse transcriptase activity but only certain forms have RNase H activity.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1711203      PMCID: PMC51712          DOI: 10.1073/pnas.88.11.4596

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  28 in total

1.  Biochemical heterogeneity of reverse transcriptase purified from the AIDS virus, HTLV-III.

Authors:  A Chandra; T Gerber; P Chandra
Journal:  FEBS Lett       Date:  1986-03-03       Impact factor: 4.124

2.  Expression of reverse transcriptase activity of human T-lymphotropic virus type III (HTLV-III/LAV) in Escherichia coli.

Authors:  N Tanese; J Sodroski; W A Haseltine; S P Goff
Journal:  J Virol       Date:  1986-09       Impact factor: 5.103

3.  The N-terminal env-derived amino acids of v-rel are required for full transforming activity.

Authors:  K Garson; H Percival; C Y Kang
Journal:  Virology       Date:  1990-07       Impact factor: 3.616

4.  Complete nucleotide sequence of the AIDS virus, HTLV-III.

Authors:  L Ratner; W Haseltine; R Patarca; K J Livak; B Starcich; S F Josephs; E R Doran; J A Rafalski; E A Whitehorn; K Baumeister
Journal:  Nature       Date:  1985 Jan 24-30       Impact factor: 49.962

5.  Analysis of retroviral pol gene products with antisera raised against fusion proteins produced in Escherichia coli.

Authors:  N Tanese; M J Roth; S P Goff
Journal:  J Virol       Date:  1986-08       Impact factor: 5.103

6.  Expression of soluble, enzymatically active, human immunodeficiency virus reverse transcriptase in Escherichia coli and analysis of mutants.

Authors:  A Hizi; C McGill; S H Hughes
Journal:  Proc Natl Acad Sci U S A       Date:  1988-02       Impact factor: 11.205

7.  Synthesis of mutant parathyroid hormone genes via site-specific recombination directed by crossover linkers.

Authors:  W L Sung; D M Zahab; C A MacDonald; C S Tam
Journal:  Gene       Date:  1986       Impact factor: 3.688

8.  Structural characterization of reverse transcriptase and endonuclease polypeptides of the acquired immunodeficiency syndrome retrovirus.

Authors:  M M Lightfoote; J E Coligan; T M Folks; A S Fauci; M A Martin; S Venkatesan
Journal:  J Virol       Date:  1986-11       Impact factor: 5.103

9.  Expression and processing of the AIDS virus reverse transcriptase in Escherichia coli.

Authors:  W G Farmerie; D D Loeb; N C Casavant; C A Hutchison; M H Edgell; R Swanstrom
Journal:  Science       Date:  1987-04-17       Impact factor: 47.728

10.  Identification and characterization of HIV-specific RNase H by monoclonal antibody.

Authors:  J Hansen; T Schulze; W Mellert; K Moelling
Journal:  EMBO J       Date:  1988-01       Impact factor: 11.598

View more
  6 in total

1.  PR domain of rous sarcoma virus Gag causes an assembly/budding defect in insect cells.

Authors:  M C Johnson; H M Scobie; V M Vogt
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

2.  Cassette mutagenesis of the reverse transcriptase of human immunodeficiency virus type 1.

Authors:  P L Boyer; A L Ferris; S H Hughes
Journal:  J Virol       Date:  1992-02       Impact factor: 5.103

3.  Reverse transcriptase and protease activities of avian leukosis virus Gag-Pol fusion proteins expressed in insect cells.

Authors:  L Stewart; V M Vogt
Journal:  J Virol       Date:  1993-12       Impact factor: 5.103

4.  Expression of human immunodeficiency virus genes using baculovirus expression system.

Authors:  C Y Kang
Journal:  Mol Biotechnol       Date:  1997-10       Impact factor: 2.695

5.  trans-acting viral protease is necessary and sufficient for activation of avian leukosis virus reverse transcriptase.

Authors:  L Stewart; V M Vogt
Journal:  J Virol       Date:  1991-11       Impact factor: 5.103

6.  Flow cytometric immunofluorescence assay for detection of antibodies to human immunodeficiency virus type 1 using insoluble precursor forms of recombinant polyproteins as carriers and antigens.

Authors:  Y W Hu; P Birch; E Balaskas; A Zeibdawi; V Scalia; S A Thériault-Valin; P Gill; M T Aye
Journal:  J Clin Microbiol       Date:  1996-06       Impact factor: 5.948

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.